Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: <i>post hoc</i> analysis of a randomized controlled trialSunao Kojima, Shigeki Moritani, Naoto Yokota et al.|Lara D. Veeken|2021Cited by 18